We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $113B
1-Year Est. Return 38.87%
This Fund
S&P 500
This Quarter Est. Return
-0.52%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$82.9B
AUM Growth
-$1.95B
Cap. Flow
-$950M
Cap. Flow %
-1.15%
Top 10 Hldgs %
17.78%
Holding
800
New
57
Increased
242
Reduced
371
Closed
71

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$704M
2
HWM icon
Howmet Aerospace
HWM
+$410M
3
NTR icon
Nutrien
NTR
+$410M
4
AXP icon
American Express
AXP
+$381M
5
STLA icon
Stellantis
STLA
+$351M

Sector Composition

Rank Sector Weight
1 Financials 29.69%
2 Technology 15.63%
3 Industrials 12.69%
4 Healthcare 11.72%
5 Energy 9.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HMC icon
426
Honda
HMC
$41.3B
$6.44M 0.01%
185,374
+32,484
+21% +$1.15M
SND icon
427
Smart Sand
SND
$220M
$6.42M 0.01%
1,103,970
-150,374
-12% -$1.24M
CVEO icon
428
Civeo
CVEO
$342M
$6.42M 0.01%
141,923
-30,378
-18% -$1.28M
IPHS
429
DELISTED
Innophos Holdings, Inc.
IPHS
$6.29M 0.01%
156,454
-10,124
-6% -$444K
BKR icon
430
Baker Hughes
BKR
$62B
$6.29M 0.01%
226,357
+8,918
+4% +$273K
KMPR icon
431
Kemper
KMPR
$1.65B
$6.28M 0.01%
110,158
-19,082
-15% -$1.17M
LGF.B
432
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$6.24M 0.01%
259,319
-17,507
-6% -$503K
PKX icon
433
POSCO
PKX
$18.2B
$6.24M 0.01%
79,086
-3,290
-4% -$278K
AGN
434
DELISTED
Allergan plc
AGN
$6.22M 0.01%
36,992
+4,133
+13% +$693K
GE icon
435
GE Aerospace
GE
$355B
$6.13M 0.01%
94,911
+17,440
+23% +$1.29M
AES icon
436
AES
AES
$10.5B
$6.02M 0.01%
529,404
-79,297
-13% -$862K
NUE icon
437
Nucor
NUE
$56.8B
$5.97M 0.01%
97,807
-1,800,679
-95% -$119M
OSPN icon
438
OneSpan
OSPN
$610M
$5.95M 0.01%
459,552
-38,388
-8% -$524K
IBCP icon
439
Independent Bank Corp
IBCP
$818M
$5.93M 0.01%
258,800
+5,100
+2% +$119K
REN
440
DELISTED
Resolute Energy Corporaton
REN
$5.86M 0.01%
169,232
-1,478
-0.9% -$50.1K
FBM
441
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
$5.85M 0.01%
392,228
-76,528
-16% -$1.15M
NFBK
442
DELISTED
Northfield Bancorp
NFBK
$5.8M 0.01%
371,820
-56,760
-13% -$930K
USAK
443
DELISTED
USA Truck Inc
USAK
$5.79M 0.01%
227,350
-142,645
-39% -$3.37M
FLIC
444
DELISTED
First of Long Island Corp
FLIC
$5.79M 0.01%
210,801
+4,100
+2% +$116K
CDR
445
DELISTED
Cedar Realty Trust, Inc
CDR
$5.75M 0.01%
221,123
-18,765
-8% -$566K
USAP
446
DELISTED
Universal Stainless & Alloy
USAP
$5.73M 0.01%
208,357
-38,835
-16% -$981K
NXRT
447
NexPoint Residential Trust
NXRT
$602M
$5.72M 0.01%
230,400
+13,300
+6% +$338K
CNBKA
448
DELISTED
Century Bancorp Inc/Mass
CNBKA
$5.72M 0.01%
72,023
-6,635
-8% -$520K
GTY
449
Getty Realty Corp
GTY
$2.04B
$5.72M 0.01%
226,683
+28,223
+14% +$706K
MNTX
450
DELISTED
Manitex International, Inc.
MNTX
$5.71M 0.01%
499,602
-31,187
-6% -$331K

Similar funds

Boston Partners's Q1 2018 Portfolio in Review

As of Q1 2018, Boston Partners held 800 positions worth $82.9B, down 2.3% from $84.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Partners's Q1 2018 filing shows 57 new, 242 increased, 371 reduced and 71 closed positions. Its largest new stake was Nutrien: 8,190,940 shares worth $387M. The largest sale was Apple, an estimated $674M.

By sector, the portfolio is most concentrated in Financials at 30% of assets, up from 29% a quarter earlier, followed by Technology and Industrials.

  • Boston Partners's largest Q1 2018 buy was Nutrien: 8,190,940 shares worth $387M.
  • Boston Partners added most to Johnson & Johnson in Q1 2018, an estimated $704M increase.
  • Boston Partners's biggest Q1 2018 reduction was Apple, cutting an estimated $674M.
  • Boston Partners fully exited Sanofi in Q1 2018, selling an estimated $364M.
  • Boston Partners's ten largest holdings make up 18% of its $82.9B portfolio in Q1 2018.
  • Boston Partners opened 57 new positions and closed 71 in Q1 2018.
  • Boston Partners's portfolio value fell 2.3% quarter-over-quarter to $82.9B.

Based on Boston Partners's 13F filing for Q1 2018, filed 4 May 2018.